The discovery of penicillin at St Mary's Hospital in London is one of the most famous milestones in medical history. Popular retellings often frame the event through a dramatic, romantic lens—implying that a flash of absolute luck or mysterious laboratory conditions changed medicine overnight. Strip away the folklore, and you find a story driven by decades of persistent bacteriological research, astute observation, and subsequent collaborative effort that turned a contaminated petri dish into a global therapeutic revolution.
The September 1928 Discovery at St Mary's
In September 1928, Scottish bacteriologist Alexander Fleming returned to his cluttered laboratory at St Mary's Hospital after a summer holiday. He was actively investigating variants of Staphylococcus aureus, the bacterium responsible for boils, abscesses, and various hospital-acquired infections.
Before leaving, Fleming had stacked several culture plates on a bench near an open window. During his absence, a spore of a rare mold—later classified as Penicillium notatum (and now categorized as Penicillium chrysogenum or rubens)—drifted into the room and landed on one of the nutrient agar plates.
When Fleming examined the plate, he noticed a distinct phenomenon: the colonies of Staphylococcus surrounding the invading mold colony had undergone lysis, appearing translucent and dissolving away. Rather than discarding the ruined experiment, Fleming recognized that the mold was secreting an inhibitory substance that diffused through the agar and killed the surrounding bacteria. He named this active secretion "penicillin" in March 1929.
Beyond Serendipity: Why Preparation Mattered
Popular history often reduces Fleming's breakthrough to pure accident, suggesting any observer would have thrown out the plate or noticed the same thing. In reality, Fleming possessed the precise scientific background required to interpret the anomaly.
Years prior, in 1922, Fleming had discovered lysozyme, an antibacterial enzyme present in human tears, saliva, and nasal mucus. That prior discovery trained his eye to spot zones of bacterial inhibition on crowded culture plates. If a less experienced researcher had encountered the mold contamination, the plate likely would have ended up in the incinerator without a second thought. Fleming understood that microbes could produce chemical weapons against competing bacteria, giving him the conceptual framework to value what he saw.
The Barrier of Purification and Isolation
Discovering the existence of penicillin was only the first hurdle. Proving its clinical value required isolating the active compound in stable, concentrated quantities—a task that pushed past the limits of Fleming's laboratory.
Fleming and his assistants, Stuart Craddock and Frederick Ridley, attempted to extract and concentrate the substance from broth cultures. They found that penicillin was exceptionally unstable. It degraded rapidly when exposed to heat, varying pH levels, and routine chemical purification steps.
Because Fleming was primarily a bacteriologist rather than a trained organic chemist, he could not solve the complex stabilization puzzle. He published his findings in the British Journal of Experimental Pathology in 1929, noting penicillin's potential as a powerful antiseptic agent and its utility in laboratory isolation techniques, but the medical community largely treated it as a laboratory curiosity for over a decade.
From Laboratory Curiosity to Mass Production
The transformation of penicillin from a fragile mold extract into a mass-produced wonder drug occurred during the dark years of World War II, driven by an international team at the University of Oxford.
In 1939, Australian pathologist Howard Florey, German-born biochemist Ernst Chain, and their colleagues began systematically revisiting forgotten antibacterial substances. They re-examined Fleming's published papers on penicillin and successfully developed freeze-drying and solvent extraction techniques that stabilized the compound.
By 1940, Florey and Chain tested penicillin on mice infected with lethal streptococcus bacteria, achieving dramatic recoveries. Human trials followed shortly after in 1941, proving the drug's staggering capacity to conquer severe blood infections. With wartime demands surging, industrial production shifted to the United States, where fermentation tanks manufactured millions of units to treat wounded Allied soldiers, saving countless lives on the battlefield.
Common Misconceptions About the Discovery
The historical record contains several persistent myths regarding Alexander Fleming and his work.
- Myth: Fleming invented penicillin. Fleming himself frequently corrected this misconception, stating, "I did not invent penicillin. Nature did that. I only discovered it by accident."
- Myth: Penicillin was used immediately to treat patients. In reality, a twelve-year gap separated Fleming's 1928 observation from the Oxford team's successful purification and clinical trials in 1940.
- Myth: Fleming worked alone. While Fleming identified the mold and its antibacterial properties, the Science History Institute notes that Oxford researchers Florey, Chain, and agricultural chemist Norman Heatley were essential to scaling and refining the drug for human medicine.
Frequently Asked Questions
What kind of mold contaminated Alexander Fleming's culture plate?
The contaminant was a rare strain of penicillium mold. It was initially identified as Penicillium notatum, though modern taxonomic classification places it within Penicillium chrysogenum (or Penicillium rubens).
Why did Alexander Fleming fail to mass-produce penicillin?
Fleming and his assistants were bacteriologists, not expert organic chemists. The chemical extraction techniques available in his lab during the late 1920s could not stabilize penicillin without destroying its antibacterial properties.
When did Alexander Fleming receive the Nobel Prize?
Fleming shared the 1945 Nobel Prize in Physiology or Medicine with Howard Florey and Ernst Chain for the discovery of penicillin and its subsequent therapeutic impact.
Did Fleming patent penicillin?
No, Fleming chose not to patent penicillin. He believed his discovery should remain freely available to benefit global public health without commercial restrictions.
